DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: One involves direct binding to the cdc25C promoter

Molecular Cell

Volumn 16, Issue 5, 2004, Pages 725-736

  Clair, Selvon St ^a   Giono, Luciana ^a   Varmeh Ziaie, Shohreh ^a   Resnick Silverman, Lois ^a   Liu, Wen Jun ^a   Padi, Abhilash ^a   Dastidar, Jayasri ^a   DaCosta, Andrea ^a   Mattia, Melissa ^a   Manfredi, James J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; DOWN REGULATION; GENE IDENTIFICATION; GENE REPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOSIS; PROMOTER REGION; PROTEIN BINDING; SEQUENCE HOMOLOGY;

BASE SEQUENCE; BINDING SITES; CDC25 PHOSPHATASE; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CELL LINE, TUMOR; CHROMATIN; CLONING, MOLECULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DOXORUBICIN; GENES, REPORTER; HISTONE DEACETYLASES; HUMANS; IMMUNOPRECIPITATION; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTATION; PLASMIDS; PROLINE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TETRACYCLINE; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSGENES; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 9744250223     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2004.11.002     Document Type: Article

References (36)

1. Borellini F., Glazer R.I. Induction of Sp1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell line TF-1. J. Biol. Chem. 268:1993;7923-7928
2. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.W., Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 282:1998;1497-1501
3. Chan T.A., Hermeking H., Lengauer C., Kinzler K.W., Vogelstein B. 14-3-3 sigma is required to prevent mitotic catastrophe after DNA damage. Nature. 401:1999;616-620
4. Chang B.D., Broude E.V., Fang J., Kalinichenko T.V., Abdryashitov R., Poole J.C., Roninson I.B. p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene. 19:2000;2165-2170
5. Desai-Yajnik V., Samuels H.H. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements. Mol. Cell. Biol. 13:1993;5057-5069
6. el-Deiry W.S. Regulation of p53 downstream genes. Semin. Cancer Biol. 8:1998;345-357
7. Espinosa J.M., Verdun R.E., Emerson B.M. p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol. Cell. 12:2003;1015-1027
8. Flatt P.M., Tang L.J., Scatena C.D., Szak S.T., Pietenpol J.A. p53 regulation of G(2) checkpoint is retinoblastoma protein dependent. Mol. Cell. Biol. 20:2000;4210-4223
9. Gualberto A., Baldwin A.S. Jr. p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat. J. Biol. Chem. 270:1995;19680-19683
10. Hermeking H., Lengauer C., Polyak K., He T.C., Zhang L., Thiagalingam S., Kinzler K.W., Vogelstein B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell. 1:1997;3-11
11. Krause K., Haugwitz U., Wasner M., Wiedmann M., Mossner J., Engeland K. Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumor suppressor protein p53 but not by p73. Biochem. Biophys. Res. Commun. 284:2001;743-750
12. Lee K.C., Crowe A.J., Barton M.C. p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding. Mol. Cell. Biol. 19:1999;1279-1288
13. Liu N., Lucibello F.C., Korner K., Wolfraim L.A., Zwicker J., Muller R. CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters. Nucleic Acids Res. 25:1997;4915-4920
14. Lohr K., Moritz C., Contente A., Dobbelstein M. p21/CDKN1A mediates negative regulation of transcription by p53. J. Biol. Chem. 278:2003;32507-32516
15. Ludwig R.L., Bates S., Vousden K.H. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol. Cell. Biol. 16:1996;4952-4960
16. Manni I., Mazzaro G., Gurtner A., Mantovani R., Haugwitz U., Krause K., Engeland K., Sacchi A., Soddu S., Piaggio G. NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest. J. Biol. Chem. 276:2001;5570-5576
17. McCoy C., Smith D.E., Cornwell M.M. 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1. Mol. Cell. Biol. 15:1995;6100-6108
18. Minc E., de Coppet P., Masson P., Thiery L., Dutertre S., Amor-Gueret M., Jaulin C. The human copper-zinc superoxide dismutase gene (SOD1) proximal promoter is regulated by Sp1, Egr-1, and WT1 via non-canonical binding sites. J. Biol. Chem. 274:1999;503-509
19. Morgan D.O. Cyclin-dependent kinases. engines, clocks, and microprocessors Annu. Rev. Cell Dev. Biol. 13:1997;261-291
20. Murphy M., Ahn J., Walker K.K., Hoffman W.H., Evans R.M., Levine A.J., George D.L. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev. 13:1999;2490-2501
21. Nilsson I., Hoffmann I. Cell cycle regulation by the Cdc25 phosphatase family. Prog. Cell Cycle Res. 4:2000;107-114
22. Ohlsson C., Kley N., Werner H., LeRoith D. p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line. interaction between p53 and Sp1 Endocrinology. 139:1998;1101-1107
23. Piwnica-Worms H. Cell cycle. Fools rush in. Nature. 401:1999;535-537
24. Resnick-Silverman L., St Clair S., Maurer M., Zhao K., Manfredi J.J. Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev. 12:1998;2102-2107
25. Seto E., Usheva A., Zambetti G.P., Momand J., Horikoshi N., Weinmann R., Levine A.J., Shenk T. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA. 89:1992;12028-12032
26. Shingu T., Bornstein P. Overlapping Egr-1 and Sp1 sites function in the regulation of transcription of the mouse thrombospondin 1 gene. J. Biol. Chem. 269:1994;32551-32557
27. Skerka C., Decker E.L., Zipfel P.F. A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1. J. Biol. Chem. 270:1995;22500-22506
28. Sugrue M.M., Shin D.Y., Lee S.W., Aaronson S.A. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc. Natl. Acad. Sci. USA. 94:1997;9648-9653
29. Tang H.Y., Zhao K., Pizzolato J.F., Fonarev M., Langer J.C., Manfredi J.J. Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53. J. Biol. Chem. 273:1998;29156-29163
30. Taylor W.R., Stark G.R. Regulation of the G2/M transition by p53. Oncogene. 20:2001;1803-1815
31. Taylor W.R., Schonthal A.H., Galante J., Stark G.R. p130/E2F4 binds to and represses the cdc2 promoter in response to p53. J. Biol. Chem. 276:2001;1998-2006
32. Thornborrow E.C., Manfredi J.J. One mechanism for cell type-specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element. J. Biol. Chem. 274:1999;33747-33756
33. Thornborrow E.C., Manfredi J.J. The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter. J. Biol. Chem. 276:2001;15598-15608
34. Thornborrow E.C., Patel S., Mastropietro A.E., Schwartzfarb E.M., Manfredi J.J. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes. Oncogene. 21:2002;990-999
35. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature. 408:2000;307-310
36. Zwicker J., Gross C., Lucibello F.C., Truss M., Ehlert F., Engeland K., Muller R. Cell cycle regulation of cdc25C transcription is mediated by the periodic repression of the glutamine-rich activators NF-Y and Sp1. Nucleic Acids Res. 23:1995;3822-3830